PRESS RELEASE U.S. Drug Enforcement Administration approves import of a pharmaceutical-grade medical cannabis product produced by Tilray into the United States for a clinical trial focused on Essential Tremor NANAIMO, B.C. – Tilray Inc. (NASDAQ:TLRY) today announced that the U.S. Drug Enforcement Administration (DEA) has granted approval to import a cannabinoid study drug into the […]